Harbin Gloria Pharmaceuticals (002437) — Long-term Investment Intensity
Harbin Gloria Pharmaceuticals (002437) has a Long-term Investment Intensity of 8.1% as of September 2019. Long-term investments of CN¥776.39 Million represent 8.1% of total assets of CN¥9.61 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Harbin Gloria Pharmaceuticals net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Harbin Gloria Pharmaceuticals Long-term Investment Intensity (2015–2018)
This chart shows how Harbin Gloria Pharmaceuticals's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 8.1%, reflecting long-term investments of CN¥776.39 Million against total assets of CN¥9.61 Billion CNY. Also explore 002437 total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Harbin Gloria Pharmaceuticals (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Harbin Gloria Pharmaceuticals from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Harbin Gloria Pharmaceuticals.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 8.1% | CN¥766.54 Million | CN¥9.48 Billion | ▲ +2.4 pp |
| 2017 | 5.7% | CN¥517.83 Million | CN¥9.06 Billion | ▲ +0.2 pp |
| 2016 | 5.5% | CN¥480.37 Million | CN¥8.67 Billion | ▲ +3.7 pp |
| 2015 | 1.9% | CN¥154.68 Million | CN¥8.32 Billion | — |